Clinical Trial Update: Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 head-to-head comparison of standard-dose clopidogrel versus low-dose prasugrel in elderly patients with acute cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Effient (prasugrel) (prasugrel)
• Plavix (clopidogrel) (clopidogrel)

Snippet

Sponsor: Gennaro Sardella | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN